GSK-204946

Study Sponsor: GSK

Study Title

A single center, two part, randomized, open label cross-over study to evaluate the effect of itraconazole and rifampicin on the pharmacokinetics of GSK525762 in healthy female subjects of non child bearing potential

Medicine or Vaccine (generic name)

molibresib

Sponsor Identification Number

204946

Trial Registry Identification Number(#'s)

NCT02706535

Medical Condition

Neoplasms

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204946

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02706535

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

September 2020